相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry
Erik Bivehed et al.
PEPTIDES (2017)
Safety concerns with long-term opioid use
Michael Harned et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Expression and physiology of opioid receptors in the gastrointestinal tract
Paula Mosinska et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)
Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation
Yang Sun et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice
M. Salaga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice
Marta Zielinska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Where are we heading to in pharmacological IBD therapy?
Gerhard Rogler
PHARMACOLOGICAL RESEARCH (2015)
Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?
Magdalena Mizerska-Dudka et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2015)
Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
A. M. W. Taylor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The cholinergic anti-inflammatory pathway: A critical review
D. Martelli et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2014)
Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
Maciej Salaga et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models
Rebeca Martin et al.
INFLAMMATORY BOWEL DISEASES (2014)
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M. Salaga et al.
JOURNAL OF CROHNS & COLITIS (2014)
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
Marta Sobczak et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: New potential treatment of abdominal pain associated with inflammatory bowel diseases
Marta Sobczak et al.
PEPTIDES (2014)
Marine Hydroquinone Zonarol Prevents Inflammation and Apoptosis in Dextran Sulfate Sodium-Induced Mice Ulcerative Colitis
Sohsuke Yamada et al.
PLOS ONE (2014)
Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases
Marta Sobczak et al.
PHARMACOLOGICAL REPORTS (2014)
Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases
Marta Sobczak et al.
PHARMACOLOGICAL REPORTS (2014)
Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
Tim Raine
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)
The interplay between the gut microbiota and the immune system
Markus B. Geuking et al.
GUT MICROBES (2014)
Novel Orally Available Salvinorin A Analog PR-38 Inhibits Gastrointestinal Motility and Reduces Abdominal Pain in Mouse Models Mimicking Irritable Bowel Syndrome
M. Salaga et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract
Maciej Salaga et al.
DRUG DISCOVERY TODAY (2013)
Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum
Elzbieta Kamysz et al.
JOURNAL OF PEPTIDE SCIENCE (2013)
Tissue Inhibitor of Metalloproteinase-3 Regulates Inflammation in Human and Mouse Intestine
Ivan Monteleone et al.
GASTROENTEROLOGY (2012)
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors
Jakub Fichna et al.
INFLAMMATORY BOWEL DISEASES (2012)
Transient Receptor Potential Vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Mu Opioid Signaling Protects Against Acute Murine Intestinal Injury in a Manner Involving Stat3 Signaling
Jason R. Goldsmith et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo
Gabriella Aviello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Enzymatic degradation of endomorphins
Anna Janecka et al.
PEPTIDES (2008)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat
Kelvin P. Davies et al.
BJU INTERNATIONAL (2007)
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways
Anne Wisner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation
D. Philippe et al.
GUT (2006)
The endogenous androgen-regulated sialorphin modulates male rat sexual behavior
M Messaoudi et al.
HORMONES AND BEHAVIOR (2004)
Mechanisms of natural tolerance in the intestine - Implications for inflammatory bowel disease
RL Jump et al.
INFLAMMATORY BOWEL DISEASES (2004)
Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity
C Rougeot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation
D Philippe et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Differential role of selectins in experimental colitis
M Sans et al.
GASTROENTEROLOGY (2001)